Periscope Capital’s Aspire Biopharma Holdings, Inc. Common Stock ASBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15K | Hold |
75,000
| – | – | ﹤0.01% | 192 |
|
|
2025
Q1 | $33.8K | Buy |
+75,000
| New | +$33.8K | 0.01% | 129 |
|
|
2024
Q2 | – | Sell |
-175,000
| Closed | -$1.93M | – | 357 |
|
|
2024
Q1 | $1.93M | Hold |
175,000
| – | – | 0.49% | 64 |
|
|
2023
Q4 | $1.91M | Sell |
175,000
-26,050
| -13% | -$284K | 0.32% | 106 |
|
|
2023
Q3 | $2.18M | Buy |
201,050
+50,000
| +33% | +$542K | 0.25% | 146 |
|
|
2023
Q2 | $1.6M | Sell |
151,050
-1,181,471
| -89% | -$12.5M | 0.12% | 235 |
|
|
2023
Q1 | $14M | Buy |
1,332,521
+294,853
| +28% | +$3.1M | 0.65% | 28 |
|
|
2022
Q4 | $10.7M | Buy |
1,037,668
+73,000
| +8% | +$752K | 0.46% | 41 |
|
|
2022
Q3 | $9.78M | Buy |
964,668
+227,368
| +31% | +$2.31M | 0.28% | 97 |
|
|
2022
Q2 | $7.36M | Buy |
+737,300
| New | +$7.36M | 0.2% | 195 |
|